The	O
role	O
of	O
hypoxia	O
in	O
2	O
-	O
butoxyethanol	O
-	O
induced	O
hemangiosarcoma	B-Cancer
.	O

To	O
understand	O
the	O
molecular	O
mechanisms	O
underlying	O
compound	O
-	O
induced	O
hemangiosarcomas	B-Cancer
in	O
mice	O
,	O
and	O
therefore	O
,	O
their	O
human	O
relevance	O
,	O
a	O
systems	O
biology	O
approach	O
was	O
undertaken	O
using	O
transcriptomics	O
and	O
Causal	O
Network	O
Modeling	O
from	O
mice	O
treated	O
with	O
2	O
-	O
butoxyethanol	O
(	O
2	O
-	O
BE	O
)	O
.	O

2	O
-	O
BE	O
is	O
a	O
hemolytic	O
agent	O
that	O
induces	O
hemangiosarcomas	B-Cancer
in	O
mice	O
.	O

We	O
hypothesized	O
that	O
the	O
hemolysis	O
induced	O
by	O
2	O
-	O
BE	O
would	O
result	O
in	O
local	O
tissue	B-Tissue
hypoxia	O
,	O
a	O
well	O
-	O
documented	O
trigger	O
for	O
endothelial	B-Cell
cell	I-Cell
proliferation	O
leading	O
to	O
hemangiosarcoma	B-Cancer
.	O

Gene	O
expression	O
data	O
from	O
bone	B-Multi-tissue_structure
marrow	I-Multi-tissue_structure
(	O
BM	B-Multi-tissue_structure
)	O
,	O
liver	B-Organ
,	O
and	O
spleen	B-Organ
of	O
mice	O
exposed	O
to	O
a	O
single	O
dose	O
(	O
4	O
h	O
)	O
or	O
seven	O
daily	O
doses	O
of	O
2	O
-	O
BE	O
were	O
used	O
to	O
develop	O
a	O
mechanistic	O
model	O
of	O
hemangiosarcoma	B-Cancer
.	O

The	O
resulting	O
mechanistic	O
model	O
confirms	O
previous	O
work	O
proposing	O
that	O
2	O
-	O
BE	O
induces	O
macrophage	B-Cell
activation	O
and	O
inflammation	O
in	O
the	O
liver	B-Organ
.	O

In	O
addition	O
,	O
the	O
model	O
supports	O
local	O
tissue	B-Tissue
hypoxia	O
in	O
the	O
liver	B-Organ
and	O
spleen	B-Organ
,	O
coupled	O
with	O
increased	O
erythropoeitin	O
signaling	O
and	O
erythropoiesis	O
in	O
the	O
spleen	B-Organ
and	O
BM	B-Multi-tissue_structure
,	O
and	O
suppression	O
of	O
mechanisms	O
that	O
contribute	O
to	O
genomic	O
stability	O
,	O
events	O
that	O
could	O
be	O
contributing	O
factors	O
to	O
hemangiosarcoma	B-Cancer
formation	O
.	O

Finally	O
,	O
an	O
immunohistochemistry	O
method	O
(	O
Hypoxyprobe	O
)	O
demonstrated	O
that	O
tissue	B-Tissue
hypoxia	O
was	O
present	O
in	O
the	O
spleen	B-Organ
and	O
BM	B-Multi-tissue_structure
.	O

Together	O
,	O
the	O
results	O
of	O
this	O
study	O
identify	O
molecular	O
mechanisms	O
that	O
initiate	O
hemangiosarcoma	B-Cancer
,	O
a	O
key	O
step	O
in	O
understanding	O
safety	O
concerns	O
that	O
can	O
impact	O
drug	O
decision	O
processes	O
,	O
and	O
identified	O
hypoxia	O
as	O
a	O
possible	O
contributing	O
factor	O
for	O
2	O
-	O
BE	O
-	O
induced	O
hemangiosarcoma	B-Cancer
in	O
mice	O
.	O

